Stock DETEC DETECTION TECHNOLOGY OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Financials Detection Technology Oyj

Equities

DETEC

FI4000115464

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki
Other stock markets
 10:09:06 2024-05-03 am EDT 		5-day change 1st Jan Change
15.75 EUR +0.64% Intraday chart for Detection Technology Oyj +2.94% +14.96%
Apr. 25 Kromek rises on USD2.9 million order from US federal customer AN
Apr. 25 AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract AN

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 368 343.6 429.4 247.7 200.8 229.4 - -
Enterprise Value (EV) 1 347.6 324.2 401.8 227.1 188.1 208.4 202.7 196.3
P/E ratio 29.4 x 50.9 x 46.5 x 48.3 x 36.1 x 20.8 x 16.2 x 13.9 x
Yield 1.48% 1.17% 1.19% 1.18% 1.68% 2.43% 3.09% 3.64%
Capitalization / Revenue 3.59 x 4.21 x 4.78 x 2.51 x 1.93 x 2.06 x 1.85 x 1.68 x
EV / Revenue 3.39 x 3.98 x 4.47 x 2.3 x 1.81 x 1.87 x 1.63 x 1.44 x
EV / EBITDA 16.9 x 26.7 x 29 x 25.2 x 16 x 11.2 x 8.97 x 7.56 x
EV / FCF 46 x 73 x 69.7 x -118 x 24.9 x 19.4 x 16.3 x 14.7 x
FCF Yield 2.17% 1.37% 1.43% -0.85% 4.01% 5.14% 6.15% 6.79%
Price to Book 6.31 x 5.87 x 5.84 x 3.4 x 2.76 x 2.95 x 2.66 x 2.45 x
Nbr of stocks (in thousands) 14,375 14,375 14,656 14,656 14,656 14,656 - -
Reference price 2 25.60 23.90 29.30 16.90 13.70 15.65 15.65 15.65
Announcement Date 2/10/20 2/2/21 2/2/22 2/2/23 2/1/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 102.5 81.56 89.81 98.58 103.8 111.2 124.3 136.7
EBITDA 1 20.6 12.13 13.86 9.025 11.76 18.6 22.61 25.95
EBIT 1 17.72 8.877 10.58 5.801 8.219 14.25 18.33 21.32
Operating Margin 17.29% 10.88% 11.78% 5.88% 7.92% 12.81% 14.75% 15.59%
Earnings before Tax (EBT) 1 16.88 8.085 11.35 5.571 7.302 13.98 18.08 21.13
Net income 1 12.48 6.735 9.309 5.116 5.502 11.3 14.42 16.89
Net margin 12.17% 8.26% 10.36% 5.19% 5.3% 10.16% 11.6% 12.35%
EPS 2 0.8700 0.4700 0.6300 0.3500 0.3800 0.7525 0.9677 1.128
Free Cash Flow 1 7.558 4.441 5.761 -1.922 7.553 10.72 12.48 13.32
FCF margin 7.38% 5.45% 6.41% -1.95% 7.28% 9.64% 10.04% 9.74%
FCF Conversion (EBITDA) 36.69% 36.61% 41.57% - 64.21% 57.63% 55.17% 51.35%
FCF Conversion (Net income) 60.59% 65.94% 61.89% - 137.28% 94.87% 86.53% 78.91%
Dividend per Share 2 0.3800 0.2800 0.3500 0.2000 0.2300 0.3800 0.4840 0.5700
Announcement Date 2/10/20 2/2/21 2/2/22 2/2/23 2/1/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 23.21 24.75 20.31 22.76 27.28 28.23 22.75 25.22 24.51 31.32 22.71 25.5 27.7 34.4
EBITDA 1 3.61 3.76 1.99 2.003 2.52 3.59 - 2.113 - 5.331 2.642 3.65 4.95 6.85
EBIT 1 3.282 2.962 1.506 1.195 0.631 2.804 1.477 1.351 1.334 4.34 1.518 2.45 3.75 5.7
Operating Margin 14.14% 11.97% 7.41% 5.25% 2.31% 9.93% 6.49% 5.36% 5.44% 13.86% 6.74% 9.61% 13.54% 16.57%
Earnings before Tax (EBT) 1 3.38 3.297 1.35 1.019 1.44 2.032 - 0.782 - 4.317 1.475 2.4 3.7 5.65
Net income 1 2.86 2.826 1 0.71 1.56 2.396 - 0.454 - 3.555 1.175 1.95 2.95 4.55
Net margin 12.32% 11.42% 4.92% 3.12% 5.72% 8.49% - 1.8% - 11.35% 5.22% 7.65% 10.65% 13.23%
EPS 2 0.2000 0.1900 0.0900 0.0500 0.0500 0.1600 0.0600 0.0300 0.0500 0.2400 0.1100 0.1350 0.2000 0.3100
Dividend per Share 2 - - - - - - - - - 0.2300 - - - -
Announcement Date 10/27/21 2/2/22 4/27/22 8/3/22 10/26/22 2/2/23 4/27/23 8/3/23 10/27/23 2/1/24 4/25/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 20.4 19.4 27.6 20.6 12.7 20.9 26.6 33.1
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 7.56 4.44 5.76 -1.92 7.55 10.7 12.5 13.3
ROE (net income / shareholders' equity) 22.7% 11.5% 14.1% 6.99% 7.56% 14.7% 17% 17.7%
ROA (Net income/ Total Assets) 16.9% 8.8% 11.1% 5.57% - 11.7% 14% 14.4%
Assets 1 73.98 76.53 83.98 91.77 - 96.95 103.1 117.1
Book Value Per Share 2 4.060 4.070 5.020 4.960 4.970 5.300 5.890 6.400
Cash Flow per Share 2 0.8100 0.5200 0.4900 -0.0200 0.6600 1.060 1.160 1.190
Capex 1 4.04 3.08 1.36 1.63 2.12 4.63 3.97 4.77
Capex / Sales 3.94% 3.78% 1.51% 1.65% 2.04% 4.16% 3.19% 3.49%
Announcement Date 2/10/20 2/2/21 2/2/22 2/2/23 2/1/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Detection Technology Oyj

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.65 EUR
Average target price
19.38 EUR
Spread / Average Target
+23.80%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Imaging Systems

1st Jan change Capi.
DETECTION TECHNOLOGY OYJ Stock Detection Technology Oyj
+14.96% 245M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Stock Shanghai United Imaging Healthcare Co., Ltd.
-3.25% 15.01B
IRAY TECHNOLOGY COMPANY LIMITED Stock iRay Technology Company Limited
-38.91% 2.8B
SONOSCAPE MEDICAL CORP. Stock SonoScape Medical Corp.
-12.68% 2.45B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Wandong Medical Technology Co.,Ltd.
-12.18% 1.46B
CORETAG, INC. Stock Coretag, Inc.
-.--% 1.12B
NANO-X IMAGING LTD. Stock Nano-X Imaging Ltd.
+47.25% 534M
DRTECH CORPORATION Stock DRTECH Corporation
-13.03% 203M
VIEWORKS CO., LTD. Stock Vieworks Co., Ltd.
+2.59% 187M
INTROMEDIC CO., LTD. Stock IntroMedic Co., Ltd.
-.--% 168M
Medical Imaging Systems
  1. Stock Market
  2. Equities
  3. DETEC Stock
  4. Financials Detection Technology Oyj